Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Summary:
Type:
Status:
Interventions:
S-892216-LAI, Placebo
Locations:
Lenexa, United States; Salt Lake City, United States;
Last Updated:
October 1, 2026
Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
Summary:
Type:
Status:
Interventions:
Pirfenidone, Placebo for pirfenidone, Upadacitinib, Placebo for upadacitinib
Locations:
San Diego, United States; Rio de Janeiro, Brazil; and 7 more
Last Updated:
October 1, 2026
Long-Term Study of COVID-19 Infection and Long COVID
Summary:
Type:
Status:
Locations:
Chapel Hill, United States
Last Updated:
September 24, 2026
SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID)
Summary:
Type:
Status:
Interventions:
Placebo, Sipavibart
Locations:
Fort Lauderdale, United States
Last Updated:
September 24, 2026
Heat thErapy And mobiLity in COVID-19 Survivors
Summary:
Type:
Status:
Interventions:
Heat therapy, Sham Control, Walking
Locations:
Omaha, United States
Last Updated:
September 23, 2026
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Summary:
Type:
Status:
Interventions:
Baricitinib, Placebo
Locations:
Tucson, United States; Los Angeles, United States; and 14 more
Last Updated:
September 21, 2026
A Study to Examine Anktiva for the Treatment of COVID-19.
Summary:
Type:
Status:
Interventions:
Anktiva
Locations:
El Segundo, United States
Last Updated:
September 21, 2026
Cross-Sectional Evaluation of Persistence of SARS-CoV-2 Remnants After Recovery From Acute Infection
Summary:
Type:
Status:
Locations:
Bethesda, United States
Last Updated:
September 15, 2026
Long-Covid-19 Alleviation Through Learning Mindfulness Study
Summary:
Type:
Status:
Interventions:
Structured mindfulness intervention
Locations:
New York, United States
Last Updated:
August 28, 2026
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
Summary:
Type:
Status:
Interventions:
IV normal saline, IV immunoglobulin
Locations:
Bethesda, United States
Last Updated:
August 25, 2026